WANETAM was established in 2009 through the support of EDCTP. The first phase of the network’s operation was implemented from 2009 to 2014. This included 14 institutions from seven countries. The network was further strengthened within the last two years by the contribution of EU member-states (Belgium and UK) initiated research project (WANETAM-plus), which ensured the inclusion of other African institutions, such as Benin.


The targeted general objectives of WANETAM 1 were:

  • To promote capacity building & technology transfer to prepare West African institutes for the successful conduct of clinical trials.
  • To create a network for sub-regional scientific collaborations.


Burkina Faso

  • Centre Muraz
  • Centre National de Recherche et de Formation sur le Paludisme


  • University of Ibadan
  • Innovative Biotech
  • Nigerian Institute for Medical Research


  • Malaria Research and Training Center
  • Serefo


  • Korle-Bu Teaching Hospital
  • Noguchi Memorial Institute for Medical Research

Guinea Bissau

  • Instituto Nacional de Saúde Pública


  • Réseau Africain de Recherche sur le SIDA
  • Institut Pasteur de Dakar

The Gambia

  • MRC Unit The Gambia at LSHTM
  • National Public Health laboratory


At the end of WANETAM 1, the network registered major achievements including:Created a collaborative research network of scientists from Anglophone, Francophone and Lusophone countries in West Africa.

  • Supported short-term trainings that built both laboratory and clinical skills in the field of HIV, Malaria, and TB as well as in cross cutting disciplines, in view to support proficiency in clinical research including TB and HIV molecular diagnostic techniques, high-throughput molecular research techniques, immunological flow cytometry and multiplex assays, GCLP and GCP, Laboratory Equipment Maintenance skills, Ethics training, community support and engagement.
  • MRCG in The Gambia and the RARS in Senegal developed their own clinical trial Units and attained laboratory accreditation ISO 15189 (KENSA/ML/30 for MCG; IQMH/3355 for LBV) while supporting sister institutions to develop their own capacities.
  • MRCT in Mali built a strong and efficient system of accreditation (Guindo A…Doumbo ATMH 2012).
  • Supported long-term academic training through MScs for early and mid-career scientists and researchers within the sub-region.
  • Facilitated hands-on surveillance training on multi-drug resistance, establishment of normal values of haematological and biochemical parameters in African subjects, and antimalarial drug resistance monitoring including molecular markers.
  • Supported the development of Biomedical Maintenance and Engineering Units at some sister institutions.